INTERRELATION AMONG SERUM LITHIUM LEVELS AND BONE METABOLISM AND SOME BIOCHEMICAL PARAMETERS IN PRE AND POST-MENAUPOSAL WOMEN
Abstract
The target of this study is to determine the interrelation among serum Li level on bone metabolism (Ca, P, Parathormon, and Vitamin-D), sex and metabolic hormones (estrogen, FSH, LH and TSH), and some biochemical parameters in premenopausal and postmenopausal women. The study is carried out with 10 women: 5 premenopausal and 5 postmenopausal women. The serum Li levels, bone metabolism indicators (i.e., ALP, Ca, P, Mg, Cu, Zn) and some biochemical parameters such as serum tryglyceride, alkalene phosphatase, total cholesterol, HDL, LDL and cholesterol levels were determined. The estrogen blood level of women in menopause period was found to be lower than that of women in pre-menopause period (p<0.01) and the FSH level was found to be higher (p<0.01). In the lipid profile the triglyceride level in the post-menopause period was found to be low (p<0.05) and HDL (p<0.001), LDL (p<0.001) and the cholesterol levels were found to be high (p<0.001). The alkalene phosphatase (p<0.001) and Vitamin-D levels (p<0.001) were found to decrease. When the mineral levels were investigated no meaningful difference was observed in the serum magnesium and copper levels while zinc (p<0.01) and phosphorus (p<0.005) levels were observed to increase, the calcium levels (p<0.05) decreased and Li levels considerably decreased (p<0.0001). According to the results obtained it was determined for the first time that Li defficiency can be related with menopause and the related diseases and thus Li therapy can be used in developing new treatment protocols of menopause as an alternative method.
References
- Marslı M S. Whitehead MI. Management of the Menapause, Bulletin, 1992, 487.426. http://bmb.oxfordjournals.org/content/48/2/426.short
- Black DM, Rosen CF. Postmenopausal Osteoporosis. N Engl J Med 2016 Jan;374:254-262. DOI: 10.1056/NEJMcp1513724
- Civitelli R, Agnusdei D, Nardi P, Zacchei F, Avioli LV, Gennari C. Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis. Calcif Tissue Int. 1988 Feb;42(2):77-86. http://www.ncbi.nlm.nih.gov/pubmed/3127028
- Valquiria A. Coronado Dorce, Joao Palermo-Neto, Lithium Effects on Estrogen-Induced Supersensitivity in Rats, Brain Research Bulletin, 1992 Aug;29(2):239-241. http://www.ncbi.nlm.nih.gov/pubmed/1525677.
- Wagner E R, Zhu G, Zhang B-Q, Luo Q, Shi Q, Huang E, Gao Y, Gao J L, Kim S H, Rastegar F, Yang K, He B C, Chen L, Zuo G W, Bi Y, Su Y, Luo J, Luo X, Huang J, Deng Z L, Reid R R, Luu H H, Haydon R C, He T C. The Therapeutic Potential of the wnt Signaling Pathway in Bone Disorders, Current Mol. Pharm. 2011 Ju;4(1):14-25. http://www.ncbi.nlm.nih.gov/pubmed/20825362
- Swiecicka A, Malige M. Lithium-Induced Hypercalcemia and Parathyroid Dysfunction, Endocrine Abstracts. 2010;21:P90. http://www.endocrine-abstracts.org/ea/0021/ea0021p90.htm
- Thase M E, Sachs G S. Bipolar depression: pharmacotherapy and related therapeutic strategies, Biol. Psychiatry. 2000 Sep:48(6):558-572. http://www.ncbi.nlm.nih.gov/pubmed/11018227.
- Da Silva C.M. L., V.G.K. Almeida, R.J. Casella, Determination of lithium in pharmaceutical formulations used in the treatment of bipolar disorder by flow injection analysis with spectrophotometric detection. Talanta. 2007 Nov;73(4): 613-620. DOI: 10.1016/j.talanta.2007.04.019.
Details
Primary Language
English
Subjects
-
Journal Section
-
Authors
Publication Date
January 8, 2017
Submission Date
July 5, 2016
Acceptance Date
-
Published in Issue
Year 2016 Volume: 3 Number: 3
Cited By
Role of alkali metal oxide type on the degradation and in vivo biocompatibility of soda‐lime‐borate bioactive glass
Journal of Biomedical Materials Research Part B: Applied Biomaterials
https://doi.org/10.1002/jbm.b.34769
